{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:22:10Z","timestamp":1790788930097,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T00:00:00Z","timestamp":1560556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T00:00:00Z","timestamp":1560556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12020-019-01978-x","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T14:02:26Z","timestamp":1560607346000},"page":"416-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hypotestosteronemia is an important factor for the development of hypertension: elevated blood pressure in orchidectomized conscious rats is reversed by different androgens"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7743-4905","authenticated-orcid":false,"given":"Mercedes","family":"Perusqu\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,15]]},"reference":[{"issue":"9","key":"1978_CR1","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/oxfordjournals.aje.a117740","volume":"142","author":"SM Haffner","year":"1995","unstructured":"S.M. Haffner, P.A. Newcomb, P.M. Marcus, B.E. Klein, R. Klein, Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. Am. J. Epidemiol. 142(9), 925\u2013934 (1995)","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"1978_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.atherosclerosis.2012.07.005","volume":"224","author":"L Wang","year":"2012","unstructured":"L. Wang, M. Szklo, A.R. Folsom, N.R. Cook, S.M. Gapstur, P. Ouyang, Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 224(1), 228\u2013234 (2012). \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.07.005","journal-title":"Atherosclerosis"},{"issue":"7","key":"1978_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1042\/CS20130140","volume":"125","author":"R Maranon","year":"2013","unstructured":"R. Maranon, J.F. Reckelhoff, Sex and gender differences in control of blood pressure. Clin. Sci. 125(7), 311\u2013318 (2013). \n                    https:\/\/doi.org\/10.1042\/CS20130140","journal-title":"Clin. Sci."},{"issue":"6","key":"1978_CR4","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1097\/HJH.0b013e3283603eb1","volume":"31","author":"B Ziemens","year":"2013","unstructured":"B. Ziemens, H. Wallaschofski, H. Volzke, R. Rettig, M. Dorr, M. Nauck, B.G. Keevil, G. Brabant, R. Haring, Positive association between testosterone, blood pressure, and hypertension in women: longitudinal findings from the Study of Health in Pomerania. J. Hypertens. 31(6), 1106\u20131113 (2013). \n                    https:\/\/doi.org\/10.1097\/HJH.0b013e3283603eb1","journal-title":"J. Hypertens."},{"issue":"7","key":"1978_CR5","doi-asserted-by":"publisher","first-page":"e100409","DOI":"10.1371\/journal.pone.0100409","volume":"9","author":"JS Brand","year":"2014","unstructured":"J.S. Brand, M.M. Rovers, B.B. Yeap, H.J. Schneider, T.P. Tuomainen, R. Haring, G. Corona, A. Onat, M. Maggio, C. Bouchard, P.C. Tong, R.Y. Chen, M. Akishita, J.A. Gietema, M.H. Gannage-Yared, A.L. Unden, A. Hautanen, N.P. Goncharov, P. Kumanov, S.A. Chubb, O.P. Almeida, H.U. Wittchen, J. Klotsche, H. Wallaschofski, H. Volzke, J. Kauhanen, J.T. Salonen, L. Ferrucci, Y.T. van der Schouw, Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies. PLoS One 9(7), e100409 (2014). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0100409","journal-title":"PLoS One"},{"key":"1978_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2261-13-30","volume":"13","author":"B Daka","year":"2013","unstructured":"B. Daka, T. Rosen, P.A. Jansson, C.A. Larsson, L. Rastam, U. Lindblad, Low sex hormone-binding globulin is associated with hypertension: a cross-sectional study in a Swedish population. BMC Cardiovasc. Disord. 13, 30\u201337 (2013). \n                    https:\/\/doi.org\/10.1186\/1471-2261-13-30","journal-title":"BMC Cardiovasc. Disord."},{"issue":"12","key":"1978_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0164116","volume":"11","author":"X Shen","year":"2016","unstructured":"X. Shen, R. Wang, N. Yu, Y. Shi, H. Li, C. Xiong, Y. Li, E.M. Wells, Y. Zhou, Reference ranges and association of age and lifestyle characteristics with testosterone, sex hormone binding globulin, and luteinizing hormone among 1166 western Chinese men. PLoS One 11(12), 1\u201316 (2016). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0164116","journal-title":"PLoS One"},{"key":"1978_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cca.2018.08.027","volume":"487","author":"Y Jiang","year":"2018","unstructured":"Y. Jiang, J. Ye, M. Zhao, A. Tan, H. Zhang, Y. Gao, Z. Lu, C. Wu, Y. Hu, Q. Wang, X. Yang, Z. Mo, Cross-sectional and longitudinal associations between serum testosterone concentrations and hypertension: results from the Fangchenggang Area Male Health and Examination Survey in China. Clin. Chim. Acta 487, 90\u201395 (2018). \n                    https:\/\/doi.org\/10.1016\/j.cca.2018.08.027","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"1978_CR9","doi-asserted-by":"publisher","first-page":"R189","DOI":"10.1152\/ajpregu.00110.2015","volume":"309","author":"M Perusquia","year":"2015","unstructured":"M. Perusquia, C.D. Greenway, L.M. Perkins, J.N. Stallone, Systemic hypotensive effects of testosterone are androgen structure-specific and neuronal nitric oxide synthase-dependent. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309(2), R189\u2013R195 (2015). \n                    https:\/\/doi.org\/10.1152\/ajpregu.00110.2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"1978_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jsbmb.2016.11.016","volume":"167","author":"M Perusquia","year":"2017","unstructured":"M. Perusquia, N. Herrera, M. Ferrer, J.N. Stallone, Antihypertensive effects of androgens in conscious, spontaneously hypertensive rats. J. Steroid Biochem. Mol. Biol. 167, 106\u2013114 (2017). \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2016.11.016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1978_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jsbmb.2017.11.001","volume":"178","author":"M Perusquia","year":"2018","unstructured":"M. Perusquia, A.E. Hanson, C.M. Meza, C. Kubli, N. Herrera, J.N. Stallone, Antihypertensive responses of vasoactive androgens in an in vivo experimental model of preeclampsia. J. Steroid Biochem. Mol. Biol. 178, 65\u201372 (2018). \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2017.11.001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"13\u201314","key":"1978_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0039-128X(02)00061-2","volume":"67","author":"M Perusquia","year":"2002","unstructured":"M. Perusquia, C.M. Villalon, The vasodepressor effect of androgens in pithed rats: potential role of calcium channels. Steroids 67(13\u201314), 1021\u20131028 (2002)","journal-title":"Steroids"},{"issue":"6","key":"1978_CR13","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1210\/endo-92-6-1579","volume":"92","author":"J Coyotupa","year":"1973","unstructured":"J. Coyotupa, A.F. Parlow, N. Kovacic, Serum testosterone and dihydrotestosterone levels following orchiectomy in the adult rat. Endocrinology 92(6), 1579\u20131581 (1973). \n                    https:\/\/doi.org\/10.1210\/endo-92-6-1579","journal-title":"Endocrinology"},{"issue":"6","key":"1978_CR14","doi-asserted-by":"publisher","first-page":"E182","DOI":"10.3390\/md16060182","volume":"16","author":"NS Bhandarkar","year":"2018","unstructured":"N.S. Bhandarkar, S.A. Kumar, J. Martin, L. Brown, S.K. Panchal, Attenuation of metabolic syndrome by EPA\/DHA ethyl esters in testosterone-deficient obese rats. Mar. Drugs 16(6), E182 (2018). \n                    https:\/\/doi.org\/10.3390\/md16060182","journal-title":"Mar. Drugs"},{"issue":"3","key":"1978_CR15","doi-asserted-by":"publisher","first-page":"e0213351","DOI":"10.1371\/journal.pone.0213351","volume":"14","author":"RA Fernandes Corr\u00eaa","year":"2019","unstructured":"R.A. Fernandes Corr\u00eaa, R.F. Ribeiro J\u00fanior, S.B.O. Mendes, P.M. Dos Santos, M.V.A. da Silva, D.F. Silva, I.P. Biral, P.R. de Batista, D.V. Vassallo, A.S. Bittencourt, I. Stefanon, A.A. Fernandes, Testosterone deficiency reduces the effects of late cardiac remodeling after acute myocardial infarction in rats. PLoS One 14(3), e0213351 (2019). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0213351","journal-title":"PLoS One"},{"issue":"3","key":"1978_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/sj.bjp.0704522","volume":"135","author":"P Tep-areenan","year":"2002","unstructured":"P. Tep-areenan, D.A. Kendall, M.D. Randall, Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br. J. Pharmacol. 135(3), 735\u2013740 (2002). \n                    https:\/\/doi.org\/10.1038\/sj.bjp.0704522","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"1978_CR17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/BF03346526","volume":"32","author":"KO Rowell","year":"2009","unstructured":"K.O. Rowell, J. Hall, P.J. Pugh, T.H. Jones, K.S. Channer, R.D. Jones, Testosterone acts as an efficacious vasodilator in isolated human pulmonary arteries and veins: evidence for a biphasic effect at physiological and supra-physiological concentrations. J. Endocrinol. Invest. 32(9), 718\u2013723 (2009). \n                    https:\/\/doi.org\/10.1007\/BF03346526","journal-title":"J. Endocrinol. Invest."},{"issue":"10","key":"1978_CR18","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1161\/01.CIR.94.10.2614","volume":"94","author":"TM Chou","year":"1996","unstructured":"T.M. Chou, K. Sudhir, S.J. Hutchison, E. Ko, T.M. Amidon, P. Collins, K. Chatterjee, Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 94(10), 2614\u20132619 (1996)","journal-title":"Circulation"},{"issue":"1","key":"1978_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1113\/jphysiol.2002.022756","volume":"543","author":"C Molinari","year":"2002","unstructured":"C. Molinari, A. Battaglia, E. Grossini, D.A. Mary, C. Vassanelli, G. Vacca, The effect of testosterone on regional blood flow in prepubertal anaesthetized pigs. J. Physiol. 543(1), 365\u2013372 (2002)","journal-title":"J. Physiol."},{"issue":"4","key":"1978_CR20","doi-asserted-by":"publisher","first-page":"H1720","DOI":"10.1152\/ajpheart.2001.281.4.H1720","volume":"281","author":"VP Deenadayalu","year":"2001","unstructured":"V.P. Deenadayalu, R.E. White, J.N. Stallone, X. Gao, A.J. Garcia, Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am. J. Physiol. Heart Circ. Physiol. 281(4), H1720\u2013H1727 (2001). \n                    https:\/\/doi.org\/10.1152\/ajpheart.2001.281.4.H1720","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"12","key":"1978_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.lfs.2007.07.024","volume":"81","author":"M Perusqu\u00eda","year":"2007","unstructured":"M. Perusqu\u00eda, E. Navarrete, L. Gonzalez, C.M. Villalon, The modulatory role of androgens and progestins in the induction of vasorelaxation in human umbilical artery. Life Sci. 81(12), 993\u20131002 (2007). \n                    https:\/\/doi.org\/10.1016\/j.lfs.2007.07.024","journal-title":"Life Sci."},{"issue":"6","key":"1978_CR22","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/sj.bjp.0705351","volume":"139","author":"ID Wakefield","year":"2003","unstructured":"I.D. Wakefield, J.E. March, P.A. Kemp, J.P. Valentin, T. Bennett, S.M. Gardiner, Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S-methyl-l-thiocitrulline and L-NAME, in conscious rats. Br. J. Pharmacol. 139(6), 1235\u20131243 (2003). \n                    https:\/\/doi.org\/10.1038\/sj.bjp.0705351","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"1978_CR23","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/1440-1681.12595","volume":"43","author":"AK Oloyo","year":"2016","unstructured":"A.K. Oloyo, O.A. Sofola, M.A. Yakubu, Orchidectomy attenuates high-salt diet-induced increases in blood pressure, renovascular resistance, and hind limb vascular dysfunction: role of testosterone. Clin. Exp. Pharm. Physiol. 43(9), 825\u2013833 (2016). \n                    https:\/\/doi.org\/10.1111\/1440-1681.12595","journal-title":"Clin. Exp. Pharm. Physiol."},{"issue":"1","key":"1978_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1556\/2060.104.2017.1.3","volume":"104","author":"SY Loh","year":"2017","unstructured":"S.Y. Loh, N. Salleh, Influence of testosterone on mean arterial pressure: A physiological study in male and female normotensive WKY and hypertensive SHR rats. Physiol. Int. 104(1), 25\u201334 (2017). \n                    https:\/\/doi.org\/10.1556\/2060.104.2017.1.3","journal-title":"Physiol. Int."},{"issue":"8","key":"1978_CR25","doi-asserted-by":"publisher","first-page":"e0137111","DOI":"10.1371\/journal.pone.0137111","volume":"10","author":"WN Rouver","year":"2015","unstructured":"W.N. Rouver, N.T. Delgado, J.B. Menezes, R.L. Santos, M.R. Moyses, Testosterone replacement therapy prevents alterations of coronary vascular reactivity caused by hormone deficiency induced by castration. PLoS One 10(8), e0137111 (2015). \n                    https:\/\/doi.org\/10.1371\/journal.pone.0137111","journal-title":"PLoS One"},{"issue":"6","key":"1978_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1024\/0301-1526\/a000466","volume":"44","author":"NT Malan","year":"2015","unstructured":"N.T. Malan, W. Smith, R. von K\u00e4nel, M. Hamer, A.E. Schutte, L. Malan, Low serum testosterone and increased diastolic ocular perfusion pressure: a risk for retinal microvasculature. Vasa 44(6), 435\u2013443 (2015). \n                    https:\/\/doi.org\/10.1024\/0301-1526\/a000466","journal-title":"Vasa"},{"key":"1978_CR27","unstructured":"K.C.S. Dixit, J. Wu, L.B. Smith, P.W.F. Hadoke, F.C.W. Wu, Androgens and coronary artery disease. In: K.R. Feingold, B. Anawalt, A. Boyce, eds. Endotext [Internet], (MDText.com, Inc., South Dartmouth, MA, 2000\u20132015)"},{"issue":"12","key":"1978_CR28","first-page":"991","volume":"16","author":"P Marin","year":"1992","unstructured":"P. Marin, S. Holmang, L. Jonsson, L. Sjostrom, H. Kvist, G. Holm, G. Lindstedt, P. Bjorntorp, The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J. Obes. Relat. Metab. Disord. 16(12), 991\u2013997 (1992)","journal-title":"Int J. Obes. Relat. Metab. Disord."},{"issue":"4","key":"1978_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/j.1550-8528.1993.tb00618.x","volume":"1","author":"P Marin","year":"1993","unstructured":"P. Marin, S. Holmang, C. Gustafsson, L. Jonsson, H. Kvist, A. Elander, J. Eldh, L. Sjostrom, G. Holm, P. Bjorntorp, Androgen treatment of abdominally obese men. Obes. Res. 1(4), 245\u2013251 (1993). \n                    https:\/\/doi.org\/10.1002\/j.1550-8528.1993.tb00618.x","journal-title":"Obes. Res."},{"issue":"3","key":"1978_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ncpuro0706","volume":"4","author":"M Zitzmann","year":"2007","unstructured":"M. Zitzmann, Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men. Nat. Clin. Pr. Urol. 4(3), 161\u2013166 (2007). \n                    https:\/\/doi.org\/10.1038\/ncpuro0706","journal-title":"Nat. Clin. Pr. Urol."},{"issue":"2","key":"1978_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.mce.2009.06.007","volume":"316","author":"PM Mah","year":"2010","unstructured":"P.M. Mah, G.A. Wittert, Obesity and testicular function. Mol. Cell Endocrinol. 316(2), 180\u2013186 (2010). \n                    https:\/\/doi.org\/10.1016\/j.mce.2009.06.007","journal-title":"Mol. Cell Endocrinol."},{"key":"1978_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/VHRM.S108947","volume":"12","author":"A Haider","year":"2016","unstructured":"A. Haider, A. Yassin, K.S. Haider, G. Doros, F. Saad, G.M. Rosano, Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-termtestosterone therapy: observational, real-life data from a registry study. Vasc. Health Risk Manag. 12, 251\u2013261 (2016). \n                    https:\/\/doi.org\/10.2147\/VHRM.S108947","journal-title":"Vasc. Health Risk Manag."},{"issue":"7","key":"1978_CR33","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1210\/jc.2003-031069","volume":"89","author":"CJ Malkin","year":"2004","unstructured":"C.J. Malkin, P.J. Pugh, R.D. Jones, D. Kapoor, K.S. Channer, T.H. Jones, The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J. Clin. Endocrinol. Metab. 89(7), 3313\u20133318 (2004). \n                    https:\/\/doi.org\/10.1210\/jc.2003-031069","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1978_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-2003-39229","volume":"111","author":"M Perusquia","year":"2003","unstructured":"M. Perusquia, Androgen-induced vasorelaxation: a potential vascular protective effect. Exp. Clin. Endocrinol. Diabetes 111(2), 55\u201359 (2003). \n                    https:\/\/doi.org\/10.1055\/s-2003-39229","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"1","key":"1978_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2007-949657","volume":"115","author":"O Yildiz","year":"2007","unstructured":"O. Yildiz, M. Seyrek, Vasodilating mechanisms of testosterone. Exp. Clin. Endocrinol. Diabetes 115(1), 1\u20136 (2007). \n                    https:\/\/doi.org\/10.1055\/s-2007-949657","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"5","key":"1978_CR36","doi-asserted-by":"publisher","first-page":"H1301","DOI":"10.1152\/ajpheart.00753.2009","volume":"298","author":"M Perusquia","year":"2010","unstructured":"M. Perusquia, J.N. Stallone, Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites. Am. J. Physiol. Heart Circ. Physiol. 298(5), H1301\u2013H1307 (2010). \n                    https:\/\/doi.org\/10.1152\/ajpheart.00753.2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"1978_CR37","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/JOE-12-0582","volume":"217","author":"DM Kelly","year":"2013","unstructured":"D.M. Kelly, T.H. Jones, Testosterone: a vascular hormone in health and disease. J. Endocrinol. 217(3), R47\u2013R71 (2013). \n                    https:\/\/doi.org\/10.1530\/JOE-12-0582","journal-title":"J. Endocrinol."},{"key":"1978_CR38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/288373a0","volume":"288","author":"RF Furchgott","year":"1980","unstructured":"R.F. Furchgott, J.V. Zawadzki, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373\u2013376 (1980)","journal-title":"Nature"},{"issue":"2","key":"1978_CR39","first-page":"109","volume":"43","author":"S Moncada","year":"1991","unstructured":"S. Moncada, R.M. Palmer, E.A. Higgs, Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43(2), 109\u2013142 (1991)","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"1978_CR40","doi-asserted-by":"publisher","first-page":"R1288","DOI":"10.1152\/ajpregu.00397.2010","volume":"300","author":"SL Bourque","year":"2011","unstructured":"S.L. Bourque, S.T. Davidge, M.A. Adams, The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300(6), R1288\u2013R1295 (2011). \n                    https:\/\/doi.org\/10.1152\/ajpregu.00397.2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"2\u20133","key":"1978_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0014-2999(99)00161-2","volume":"371","author":"M Perusqu\u00eda","year":"1999","unstructured":"M. Perusqu\u00eda, C.M. Villal\u00f3n, Possible role of Ca2+ channels in the vasodilating effect of 5beta-dihydrotestosterone in rat aorta. Eur. J. Pharmacol. 371(2\u20133), 169\u2013178 (1999). \n                    https:\/\/doi.org\/10.1016\/S0014-2999(99)00161-2","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"1978_CR42","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/00005344-200206000-00006","volume":"39","author":"RD Jones","year":"2002","unstructured":"R.D. Jones, K.M. English, P.J. Pugh, A.H. Morice, T.H. Jones, K.S. Channer, Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action. J. Cardiovasc. Pharmacol. 39(6), 814\u2013823 (2002)","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"1978_CR43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.lfs.2008.08.009","volume":"83","author":"J Navarro-Dorado","year":"2008","unstructured":"J. Navarro-Dorado, L.M. Orensanz, P. Recio, S. Bustamante, S. Benedito, A.C. Mart\u00ednez, A. Garc\u00eda-Sacrist\u00e1n, D. Prieto, M. Hern\u00e1ndez, Mechanisms involved in testosterone-induced vasodilatation in pig prostatic small arteries. Life Sci. 83, 569\u2013573 (2008). \n                    https:\/\/doi.org\/10.1016\/j.lfs.2008.08.009","journal-title":"Life Sci."},{"issue":"3\u20134","key":"1978_CR44","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.vph.2012.01.008","volume":"56","author":"M Perusqu\u00eda","year":"2012","unstructured":"M. Perusqu\u00eda, J. Espinoza, L.M. Monta\u00f1o, J.N. Stallone, Regional differences in the vasorelaxing effects of testosterone and its 5-reduced metabolites in the canine vasculature. Vasc. Pharmacol. 56(3\u20134), 176\u2013182 (2012). \n                    https:\/\/doi.org\/10.1016\/j.vph.2012.01.008","journal-title":"Vasc. Pharmacol."},{"issue":"6","key":"1978_CR45","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1210\/en.2005-1243","volume":"147","author":"J Hall","year":"2006","unstructured":"J. Hall, R.D. Jones, T.H. Jones, K.S. Channer, C. Peers, Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology 147(6), 2675\u20132680 (2006). \n                    https:\/\/doi.org\/10.1210\/en.2005-1243","journal-title":"Endocrinology"},{"issue":"2","key":"1978_CR46","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bbrc.2004.04.054","volume":"318","author":"JL Scragg","year":"2004","unstructured":"J.L. Scragg, R.D. Jones, K.S. Channer, T.H. Jones, C. Peers, Testosterone is a potent inhibitor of L-type Ca(2+) channels. Biochem. Biophys. Res. Commun. 318(2), 503\u2013506 (2004). \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2004.04.054","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1978_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ceca.2006.11.003","volume":"42","author":"JL Scragg","year":"2007","unstructured":"J.L. Scragg, M.L. Dallas, C. Peers, Molecular requirements for L-type Ca2+ channel blockade by testosterone. Cell Calcium 42, 11\u201315 (2007). \n                    https:\/\/doi.org\/10.1016\/j.ceca.2006.11.003","journal-title":"Cell Calcium"},{"issue":"5","key":"1978_CR48","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1210\/en.2007-1288","volume":"149","author":"LM Monta\u00f1o","year":"2008","unstructured":"L.M. Monta\u00f1o, E. Calixto, A. Figueroa, E. Flores-Soto, V. Carbajal, M. Perusquia, Relaxation of androgens on rat thoracic aorta: testosterone concentration dependent agonist\/antagonist L-type Ca2+ channel activity, and 5beta-dihydrotestosterone restricted to L-type Ca2+ channel blockade. Endocrinology 149(5), 2517\u20132526 (2008). \n                    https:\/\/doi.org\/10.1210\/en.2007-1288","journal-title":"Endocrinology"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01978-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-019-01978-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01978-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T23:06:37Z","timestamp":1592089597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-019-01978-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,15]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1978"],"URL":"https:\/\/doi.org\/10.1007\/s12020-019-01978-x","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,15]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All protocols were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) at the Institute for Biomedical Research, UNAM.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}